Mild-to-moderate BP trial data to be presented at EADV
Congress, October 10, 2019.
According to the EADV
, tattoo ink carries the risk of bacterial contamination, allergies and toxic effects.
To this end, he aims to mobilise consumer organisations and the European Association of Dermatologists and Venereologists (EADV
), with which he plans to publish "guidelines" on artificial tanning in all the EU's official languages.
Further data on BP patients treated as part of the Company's ongoing Phase II study will be presented at the 28th European Academy of Dermatology and Venereology (EADV
) Congress, Madrid on October 10, 2019.
Dubai Derma is organized by Index Conferences & Exhibitions - a member of Index Holding, in cooperation with the Pan Arab League of Dermatology, Arab Academy of Dermatology & Aesthetics (AADA), American Academy of Dermatology, (AAD), European Academy of Dermatology and Venereology (EADV
) and GCC League of Dermatologists with the support of the Government of Dubai and Dubai Health Authority (DHA).
These data were presented at the 27th European Academy of Dermatology and Venereology (EADV
) Congress in Paris, France.
Data from these studies will be presented at the 27th European Academy of Dermatology and Venerology, or EADV
. Risankizumab is not approved by regulatory authorities and its safety and efficacy have not been established.
EunSung will be attending the HKTDC Hong Kong International Medical Devices and Supplies Fair 2016, China Beauty Expo 2016 21st Edition, XXXIV RADLA 2016, 4th Aesthetic and Anti-Aging Medicine World Congress - Eastern Europe, and the 25th EADV
* DSM Nutritional Products reported new scientific data on skin penetration behavior of Parsol SLX, the first polymeric sunscreen approved for skin protection, at the European Dermatology and Venerology Congress (EADV
) 2010 in Gothenburg.
These long-term findings from the Phase III VOYAGE 1 and 2 clinical trial programmes are part of six abstracts Janssen presented at the European Academy of Dermatology and Venereology (EADV
) 2018 Congress in Paris, France.
In addition, data from the Phase 2 study describing biomarker changes and the selectivity of BMS-986165 for TYK2 in relation to clinical responses will be presented at EADV